A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

Leukemia. 2014 Jul;28(7):1570-2. doi: 10.1038/leu.2014.85. Epub 2014 Feb 26.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Female
  • Humans
  • Leukemia, Myelomonocytic, Chronic / drug therapy*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine